Roger Jeffs

Affiliations

  • at Axsome Therapeutics Inc. (AXSM), 2025-06-10
  • Chief Executive Officer at Liquidia Corp (LQDA), 2025-06-05
  • Director at Albireo Pharma Inc. (ALBO), 2021-06-28
  • Director at Dova Pharmaceuticals Inc. (DOVA), 2019-11-12
  • Director at Axovant Sciences Ltd. (AXGT), 2019-04-18
  • Director at Sangamo Therapeutics Inc (SGMO), 2018-09-07
  • Other at United Therapeutics Corp (UTHR), 2016-06-27
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LQDA $7.16 139,665 $1,000,001.40 640,805 2023-12-14 Filing
LQDA $5.57 43,820 $243,989.76 159,827 2022-09-06 Filing
LQDA $4.90 993 $4,870.17 116,007 2022-08-31 Filing
LQDA $3.53 28,000 $98,812.00 46,595 2022-05-24 Filing
AXSM $37.30 3,950 $147,350.01 120,756 2021-11-19 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LQDA $16.97 30,610 $519,451.70 1,044,979 2025-06-04 Filing
LQDA $13.57 14,130 $191,744.10 1,006,420 2025-04-14 Filing
LQDA $11.78 22,343 $263,200.54 1,019,177 2025-01-14 Filing
LQDA $11.11 8,053 $89,450.31 812,193 2024-10-14 Filing
LQDA $12.53 8,053 $100,904.09 818,932 2024-07-12 Filing